Clinical Trials Browser

Withdrawn × Primary Myelofibrosis × pelcitoclax × Clear all

NCT04354727 2022-07-12

A Study of APG-1252 in Patients With Myelofibrosis Who Progressed After Initial Therapy

Phase 1/2 Withdrawn

Polycythemia Vera, Thrombocytosis, Primary Myelofibrosis